Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPreferred Stock LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bowhead Specialty Holdings (BOW) Cash & Equivalents (2022 - 2026)

Bowhead Specialty Holdings' Cash & Equivalents history spans 4 years, with the latest figure at $193.5 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 98.56% to $193.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $193.5 million, a 98.56% increase, with the full-year FY2025 number at $193.5 million, up 98.56% from a year prior.
  • Cash & Equivalents hit $193.5 million in Q4 2025 for Bowhead Specialty Holdings, down from $197.9 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for BOW hit a ceiling of $197.9 million in Q3 2025 and a floor of $64.7 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $121.7 million across 4 years, with a median of $116.4 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 148.3% in 2024 and later plummeted 36.33% in 2025.
  • Tracing BOW's Cash & Equivalents over 4 years: stood at $64.7 million in 2022, then surged by 82.6% to $118.1 million in 2023, then fell by 17.44% to $97.5 million in 2024, then surged by 98.56% to $193.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for BOW at $193.5 million in Q4 2025, $197.9 million in Q3 2025, and $114.8 million in Q2 2025.